Recent YSCC Discoveries

Yale School of Medicine receives $10M from the Blavatnik Family Foundation to launch a new inflammation science initiative.

In a new study, Yale researchers found aging weakens the structures that help eggs reduce their chromosome numbers accurately.

A novel study, with authors from the Department of Pediatrics and the Yale Child Study Center, on genotype-phenotype correlations in autism and the challenging analysis of comparing genetic and EEG data was recently published in the Journal of Neural Transmission.

The new drug, bavdegalutamide, activates the body’s own protein degradation system against prostate cancer.

Researchers at Yale School of Medicine have developed two approaches that improve the amount and integrity of RNA that can be recovered from precision-cut lung slices, giving researchers better tools to study living human lung tissue outside the body.

David Hafler, MD, shares his knowledge about multiple sclerosis diagnosis and treatment with local Fox 61.

Yale School of Medicine co-leads The Consortium for Hereditary Epidermal Differentiation Disorders, (CHEDD), which has received a five-year award to examine a large group of rare genetic skin disorders.

In a new study published in Nature Communications, Yale researchers used advanced cell profiling techniques to obtain the most detailed view yet of how kidney and immune cells interact in acute interstitial nephritis.

Meet some of the new professors in the Yale Department of Internal Medicine: Kathleen Akgün, MD, MS; David Calfee, MD, MS; Stefania Nicoli, PhD.